Nelonemdaz, formerly known as Neu-2000, is a NMDA receptor antagonist potentially for the treatment of stroke. References: Visavadiya NP, McEwen ML, Pandya JD, Sullivan PG, Gwag BJ, Springer JE. Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage. Toxicol In Vitro. 2013 Mar;27(2):788-97. doi: 10.1016/j.tiv.2012.12.011. PubMed PMID: 23268106.

纯度：≥98%

CAS：640290-67-1